Researchers develop novel platform to improve immunotherapy
Recent advances in immunotherapy for cancer have stimulated a plethora of studies aimed at developing T cells and Natural Killer (NK) cells in-vitro from pluripotent stem cells. Researchers have discovered a novel pathway based on Notch stimulation very early during the in-vitro differentiation that robustly support the emergence of T and NK cells from human induced Pluripotent Stem Cells (iPSC).
Materials provided by Boston University School of Medicine. Note: Content may be edited for style and length.
Source link aaaaa